mifepristone has been researched along with ulipristal in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forcelledo, ML; Poyser, NL | 1 |
| Gu, QQ; Hendrickx, AG; Lasley, BL; Matlin, SA; Tarantal, AF; Thomas, CA; Van Look, PF; Vince, PM | 1 |
| Blye, RP; Cessac, JW; Kim, HK; Rao, PN | 1 |
| Blye, RP; Hild-Petito, S; Reel, JR | 1 |
| Acosta, CK; Bahr, ML; Cessac, JW; Kim, HK; Rao, PN | 1 |
| Lasley, BL; Overstreet, JW; Stewart, DR; VandeVoort, CA | 1 |
| Blye, RP; Hild, SA; Hoffman, LH; Reel, JR | 1 |
| Blye, RP; Larner, JM; Reel, JR | 1 |
| Attardi, BJ; Blye, RP; Burgenson, J; Hild, SA; Reel, JR | 1 |
| Gainer, EE; Ulmann, A | 1 |
| Attardi, BJ; Burgenson, J; Hild, SA; Reel, JR | 1 |
| Guo, SW; Wu, Y | 1 |
| Leo, JC; Lin, VC | 1 |
| Eisinger, S; Fiscella, K | 1 |
| Spitz, IM | 1 |
| Benagiano, G; von Hertzen, H | 1 |
| Bhathena, R | 1 |
| Harrison, DJ; Mitroka, JG | 1 |
| Goyeneche, AA; Seidel, EE; Telleria, CM | 1 |
| Fan, H; Guo, W; Hou, Y; Hu, Y; Li, P; Zhao, G | 1 |
| Gamarra-Luques, CD; Goyeneche, AA; Hapon, MB; Telleria, CM | 1 |
| Bloom, DC; Feller, J; McAnany, P; Vilaboa, N; Voellmy, R | 1 |
| Choi, MR; Christov, K; Ivancic, D; Khan, SA; Lee, O | 1 |
| Chen, H; Fu, J; Huang, W; Song, H; Wang, Y; Zhou, M; Zhu, H | 1 |
| Altinoz, MA; Elmaci, I; Ozpinar, A | 1 |
3 review(s) available for mifepristone and ulipristal
| Article | Year |
|---|---|
Clinical utility of progesterone receptor modulators and their effect on the endometrium.
Topics: Drug Administration Schedule; Endometriosis; Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Oximes; Randomized Controlled Trials as Topic; Receptors, Progesterone; Time Factors; Uterine Neoplasms | 2009 |
Progesterone receptor modulators for endometriosis.
Topics: Danazol; Dysmenorrhea; Dyspareunia; Endometriosis; Estrenes; Female; Gestrinone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leuprolide; Mifepristone; Norpregnadienes; Oximes; Prevalence; Randomized Controlled Trials as Topic; Receptors, Progesterone | 2017 |
Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Topics: Animals; Antineoplastic Agents, Hormonal; Brain Neoplasms; Female; Glioma; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Meningioma; Mifepristone; Norpregnadienes; Progesterone; Progestins; Receptors, Progesterone | 2019 |
23 other study(ies) available for mifepristone and ulipristal
| Article | Year |
|---|---|
A comparison of the pregnancy-terminating potencies of three anti-progestins in guinea-pigs, and the effects of sulprostone.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Dinoprostone; Drug Evaluation, Preclinical; Drug Synergism; Estrenes; Female; Guinea Pigs; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progestins | 1994 |
Effects of two antiprogestins on early pregnancy in the long-tailed macaque (Macaca fascicularis).
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Animals; Female; Gestational Age; Macaca fascicularis; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progesterone; Progestins | 1996 |
11 beta-substituted 13 beta-ethyl gonane derivatives exhibit reversal of antiprogestational activity.
Topics: Animals; Biological Assay; Female; Gonanes; Hormone Antagonists; Levonorgestrel; Mifepristone; Norpregnadienes; Progestins; Rabbits; Receptors, Glucocorticoid; Receptors, Progesterone | 1998 |
Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats.
Topics: Animals; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fertility; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Rats; Rats, Sprague-Dawley | 1998 |
Synthesis of N-desmethyl derivatives of 17alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-die ne-3,20-dione and mifepristone1: substrates for the synthesis of radioligands.
Topics: Magnetic Resonance Spectroscopy; Mifepristone; Norpregnadienes; Radioimmunoassay; Radioligand Assay | 1999 |
Effects of progesterone receptor blockers on human granulosa-luteal cell culture secretion of progesterone, estradiol, and relaxin.
Topics: Cells, Cultured; Chorionic Gonadotropin; Estradiol; Female; Granulosa Cells; Humans; Luteal Cells; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progesterone; Receptors, Progesterone; Relaxin; Time Factors | 2000 |
CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits.
Topics: Animals; Contraceptives, Postcoital, Synthetic; Copulation; Female; Glucocorticoids; Hormone Antagonists; Male; Mifepristone; Norpregnadienes; Pregnancy; Progestins; Rabbits; Rats; Rats, Sprague-Dawley | 2000 |
Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Contraceptives, Postcoital, Synthetic; Dosage Forms; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Macaca mulatta; Mifepristone; Norpregnadienes; Sex Hormone-Binding Globulin; Transcortin | 2000 |
CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alkaline Phosphatase; Animals; Binding, Competitive; Enzyme Induction; Hormone Antagonists; Luciferases; Mifepristone; Norpregnadienes; Plasmids; Progestins; Rabbits; Rats; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Recombinant Proteins; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2002 |
Pharmacologic properties of CDB(VA)-2914.
Topics: Administration, Oral; Animals; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Endometriosis; Female; Glucocorticoids; Hormone Antagonists; Humans; Mifepristone; Models, Chemical; Norpregnadienes; Protein Binding; Receptors, Progesterone; Steroids | 2003 |
In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.
Topics: Alkaline Phosphatase; Animals; Cell Line; Enzyme Induction; Hormone Antagonists; Mifepristone; Norpregnadienes; Progestins; Protein Binding; Rabbits; Receptors, Glucocorticoid; Receptors, Progesterone | 2004 |
Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780.
Topics: Acetylcysteine; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Enzyme Inhibitors; Estradiol; Fas Ligand Protein; fas Receptor; Female; Fulvestrant; Humans; Hydrogen Peroxide; Hydroxamic Acids; Mifepristone; Norpregnadienes; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Stromal Cells | 2006 |
The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner.
Topics: Adenoviridae; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Division; Collagen; Drug Combinations; Female; Fluorescent Antibody Technique; Hormone Antagonists; Humans; Laminin; Ligands; Mifepristone; Neoplasm Invasiveness; Norpregnadienes; Polymerase Chain Reaction; Progesterone; Protein Isoforms; Proteoglycans; Receptors, Progesterone; Transfection; Tumor Cells, Cultured; Wound Healing | 2008 |
CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial.
Topics: Female; Hormone Antagonists; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Quality of Life; Randomized Controlled Trials as Topic; Uterine Neoplasms | 2008 |
Towards more effective emergency contraception?
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Progesterone receptor modulators.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital, Synthetic; Female; Hormone Antagonists; Humans; Mifepristone; Norpregnadienes; Receptors, Progesterone | 2010 |
Defining reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive health.
Topics: Abortifacient Agents; Contraceptives, Postcoital, Synthetic; Female; Health Policy; Humans; Mifepristone; Misoprostol; Nonprescription Drugs; Norpregnadienes; Off-Label Use; Pharmacists; Product Surveillance, Postmarketing; Professional Role; Receptors, Progesterone; Reproductive Medicine; Risk Assessment; United States; United States Food and Drug Administration | 2011 |
Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cytostatic Agents; DNA Fragmentation; Estrenes; Female; Furans; Hormone Antagonists; Humans; Mifepristone; Norpregnadienes; Ovarian Neoplasms | 2012 |
Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells.
Topics: Animals; Cells, Cultured; CpG Islands; Decidua; Female; Hormone Antagonists; Humans; Interferon-gamma; Interleukin-12; Killer Cells, Natural; Mice; Mice, Inbred C57BL; Mifepristone; NF-kappa B; Norpregnadienes; Pregnancy; Progesterone; Progestins; Receptors, Glucocorticoid; Receptors, Progesterone; Spleen; STAT4 Transcription Factor | 2012 |
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity.
Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estrenes; Female; Furans; Hormone Antagonists; Humans; Inhibitory Concentration 50; Mifepristone; Norpregnadienes; Paclitaxel | 2014 |
Common stem--pris.
Topics: Anti-Bacterial Agents; Humans; Mifepristone; Norpregnadienes; Receptors, Progesterone; Steroids; Terminology as Topic | 2015 |
Replication-Competent Controlled Herpes Simplex Virus.
Topics: Animals; Chlorocebus aethiops; DNA-Binding Proteins; DNA, Viral; Gene Expression Regulation, Viral; Genes, Switch; Genetic Engineering; Genetic Vectors; HeLa Cells; Herpes Simplex; Herpesvirus 1, Human; Hindlimb; Hot Temperature; HSP70 Heat-Shock Proteins; Humans; Immediate-Early Proteins; Mice; Mifepristone; Norpregnadienes; Promoter Regions, Genetic; Rabbits; RNA, Messenger; Vero Cells; Viral Envelope Proteins; Viral Proteins; Virus Replication | 2015 |
Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antigens, CD34; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mifepristone; Neovascularization, Pathologic; Norpregnadienes; Progesterone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 2016 |